Pulmonary sarcomatoid carcinoma is a rare subtype of non-small cell lung cancer with a poor prognosis. We herein report on a case of pulmonary sarcomatoid carcinoma that was treated successfully by concurrent chemoradiotherapy. A 65-year-old man was diagnosed to have pulmonary pleomorphic carcinoma (clinical T4N2M0 stage IIIB). He received concurrent chemoradiotherapy (60 Gy of radiotherapy in 30 fractionations and two courses of chemotherapy with carboplatin and paclitaxel). After chemoradiotherapy, a significant reduction of the tumor size was observed. Two courses of adjuvant chemotherapy were performed. He is currently alive at 15 months after the first treatment without any recurrence or metastasis.
CITATION STYLE
Takeda, K., Matsushita, H., Kubozono, M., Tanabe, T., Ishikawa, Y., Yamamoto, T., … Jingu, K. (2016). Definitive chemoradiotherapy for advanced pulmonary sarcomatoid carcinoma. Internal Medicine, 55(22), 3325–3330. https://doi.org/10.2169/internalmedicine.55.6990
Mendeley helps you to discover research relevant for your work.